Selectquote Inc Stock Price, News & Analysis

SelectQuote, Inc. (NYSE: SLQT) reported a consolidated revenue of $159.9 million for Q1 FY2022, a 29% increase year-over-year. However, the company faced a net loss of $45.4 million, compared to a net income of $0.8 million in the previous year. The Senior segment saw revenues of $106.3 million (up 45% YoY), but Adjusted EBITDA was $(44.0) million, down from $12.1 million. The Auto & Home segment also declined 22% in revenue, highlighting mixed performance across sectors.

BrainCheck, a cognitive healthcare platform, has raised $10 million in Series B funding led by Next Coast Ventures and S3 Ventures, bringing total capital to $20 million. Strategic investors UPMC Enterprises and SelectQuote will help enhance R&D and market capabilities. BrainCheck aims to improve cognitive health care accessibility by enabling primary care physicians to conduct quick cognitive assessments. The platform addresses the growing issue of cognitive impairment, particularly among seniors, with a 10- to 15-minute test covered by Medicare.

SelectQuote (NYSE: SLQT) announced a new partnership with Ready Responders to enhance non-emergency healthcare services delivered in patients' homes. This collaboration is part of the Population Health platform, aiming to improve healthcare literacy and navigate services effectively for seniors. Over 40% of Population Health members visited emergency rooms last year, highlighting the need for accessible healthcare. Ready Responders provides on-demand care through telehealth and home visits, operating in cities like New York and Miami.

SelectQuote, Inc. (NYSE: SLQT) will announce its fiscal Q1 2022 financial results post-market on November 4, 2021. CEO Tim Danker and CFO Raff Sadun will lead a conference call at 5:00 pm ET the same day to discuss results. The company focuses on comparing insurance from trusted carriers, with significant segments including Medicare solutions. Founded in 1985, SelectQuote has recently expanded its offerings, enhancing its service model with innovative technology and skilled agents to cater to the growing senior demographic.

SelectQuote, Inc. (NYSE: SLQT) has appointed Robert 'Bob' Grant as President, effective October 28, 2021. This decision is attributed to Grant's significant contributions to the company's Senior Division and the recent launch of the Population Health platform, which complements the Medicare business. CEO Tim Danker praised Grant's leadership in driving profitable growth. Since 2019, Grant has led the Senior Division and previously held the role of Chief Revenue Officer. SelectQuote specializes in insurance solutions, particularly for the Medicare market, with a focus on providing unbiased comparisons to consumers.

SelectQuote (NYSE: SLQT) has partnered with Thriveworks to enhance its Population Health platform, offering Medicare members access to behavioral health and medication management services. This partnership aims to address the needs of approximately 46% of Population Health members who require behavioral health services. Thriveworks' network includes over 300 locations, providing both virtual and in-person care. As SelectQuote expands its Medicare business, this collaboration is envisioned to strengthen relationships with customers by fulfilling their comprehensive healthcare needs.

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote (NYSE: SLQT), a leader in unbiased insurance price comparisons, announced that CEO Tim Danker, CFO Raff Sadun, and President Bob Grant will participate in a virtual fireside chat on September 8 at 12:30 PM E.T., hosted by Piper Sandler's Jeff Garro. Interested individuals can register via the investor relations website or a provided link. SelectQuote helps consumers protect their assets with a model emphasizing unbiased comparisons and skilled agents, and serves clients through three main business lines.

Labaton Sucharow is investigating potential securities violations involving SelectQuote, Inc. (NYSE:SLQT) after the company disclosed its fourth-quarter results would be negatively affected by a 'negative cohort and tail adjustment' related to the 2019 cohort's lower second-term persistency.

This revelation led to a 20% drop in SelectQuote's share price, closing at $21.90 on May 12, 2021. Allegations include that the company made materially misleading statements regarding its financial performance during the Class Period from February 8 to May 11, 2021.

SelectQuote reported a 33% increase in consolidated revenue for Q4 FY2021, totaling $188.4 million, alongside a 42% revenue growth in its Senior segment. However, net income decreased by $16.7 million year-over-year to $3.3 million, and Adjusted EBITDA dropped 47% to $21.3 million. Full-year results showed a 76% revenue increase to $937.8 million with net income rising to $131 million. Growth in Medicare Advantage policies was notable, up 54% YOY, despite pressures on operating metrics in certain segments.